Intellectual Property

  • April 15, 2026

    NC Judge Won't Undo $4M Philips Copyright Verdict

    A North Carolina federal judge has refused to erase a $4 million jury verdict against independent service organization Transtate Equipment Co. for violations of the Digital Millennium Copyright Act, saying trial evidence provided a "firm basis" to support the jury's statutory damages award.

  • April 15, 2026

    Fed. Circ. Won't Touch DraftKings Win In PTAB Fight

    In a one-word decision Wednesday, the U.S. Court of Appeals for the Federal Circuit upheld a Patent Trial and Appeal Board decision that found a peer-to-peer gaming patent challenged by DraftKings was not valid.

  • April 15, 2026

    Willkie Adds O'Melveny Litigator To Los Angeles Office

    Willkie Farr & Gallagher LLP expanded its Los Angeles office with the recent addition of a litigator who moved her practice after nearly 15 years with O'Melveny & Myers LLP.

  • April 15, 2026

    Biopharma Co. Says Ex-Worker Used Files To Build AI Rival

    A biopharmaceutical consulting firm's ex-contractor illegally downloaded thousands of proprietary internal files and emails that he then used to launch a rival company powered by artificial intelligence, the firm claimed in a lawsuit, alleging that the former contractor violated federal trade secrets law.

  • April 15, 2026

    Re-Uz Sues Rival Over 'Eco Cup' Marks, Client Data

    A group of companies specializing in sustainable cups has sued a competitor, accusing it of infringing its marks in branding for its reusable cups and misusing its trade secrets to poach clients.

  • April 14, 2026

    2nd Circ. Mulls Bid To Save Walmart, E-Commerce Co. IP Case

    A Second Circuit panel on Tuesday grappled with a group of businesses' attempt to revive its copyright and trademark case against Walmart and an e-commerce company, with the judges wondering whether the businesses impermissibly expanded their safe harbor arguments on appeal.

  • April 14, 2026

    VLSI's Calif. IP Suit Against Intel Revived By Fed. Circ.

    The Federal Circuit breathed new life into one of VLSI Technology's patent infringement suits against Intel Corp. on Tuesday, concluding a California federal judge wrongly interpreted an agreement between the companies to limit the scope of litigation.

  • April 14, 2026

    Amazon Suit Alleges $4M Fraud By 'Refund Abuse' Ring

    Amazon launched a lawsuit Tuesday targeting architects of what the retail giant claimed is an international fraud ring known as RBK that allegedly cheated the company out of $4 million in products through a "refund abuse" scam that allows users to obtain refunds despite keeping the goods.

  • April 14, 2026

    USPTO Rejects Nike's Trademark Bid For Bronny James' Logo

    The U.S. Patent and Trademark Office has shot down Nike's attempt to register a trademark on the logo used by LeBron James' son and Los Angeles Lakers player Bronny James, although it gave the company a chance to respond to the refusal.

  • April 14, 2026

    Wash. Appeals Court Revives Podiatrist Trade Secrets Case

    An appeals court in Washington state has reinstated a case brought by a Seattle-area podiatry practice against a former employee accused of stealing patient data for his separate practice.

  • April 14, 2026

    Fed. Circ. Affirms On-Sale Bar Ax Of Car Software Patent

    The Federal Circuit on Tuesday upheld a decision invalidating a patent on modifying vehicle engine software because the invention was on sale before the patent was sought, siding with auto equipment maker Powerteq LLC and rejecting an argument that the ruling was based on hearsay.

  • April 14, 2026

    3rd Circ. Upholds J&J Injunction Bid Loss In Biosimilar Fight

    The Third Circuit on Tuesday ruled that a Johnson & Johnson subsidiary couldn't justify its bid for an order blocking Samsung Bioepis from paving the way for a Cigna unit to launch a generic version of an anti-inflammatory treatment.

  • April 14, 2026

    3 Firms Guide TPG's Bet On College Sports Rights Giant

    Alternative asset manager TPG said Tuesday it has agreed to acquire Learfield, a leading college sports media and technology company, in a deal steered by three law firms. 

  • April 14, 2026

    Mintz Can't Halt Texas Malpractice Suit For Fee Fight In Mass.

    A Massachusetts federal judge on Tuesday declined Mintz Levin Cohn Ferris Glovsky and Popeo PC's request to halt a former client's legal malpractice case against the firm in Texas federal court while the two fight over a $2 million "success fee" the law firm claims it is owed.

  • April 14, 2026

    Alleged Bootleggers Of Springsteen Merch Hit With Injunction

    A New Jersey federal judge has granted concert merchandise company Merch Traffic LLC a preliminary injunction and seizure order authorizing law enforcement officers to confiscate allegedly counterfeit Bruce Springsteen merchandise ahead of upcoming performances, including an April 20 show in the Prudential Center in Newark.

  • April 14, 2026

    Rakoff Says $300M Piracy Case Among Worst He's Seen

    U.S. District Judge Jed S. Rakoff entered default judgment Tuesday at the request of a group of music companies against the online shadow library Anna's Archive, calling the piracy instigated by the site one of the most "horrendous acts of piracy brought to my attention."

  • April 14, 2026

    Automation Co. Wants Ruling It Didn't Infringe Ocado Patents

    Warehouse robotics company Brightpick wants a Virginia federal judge to find that its artificial intelligence automation robot, Gridpicker, doesn't infringe a series of patents owned by a unit of the British grocery technology business Ocado Group.

  • April 14, 2026

    Aerospace Firm Says Ex-Consultants Built 'Copycat' Rival

    A woman-owned aerospace and defense manufacturing company accused its former business consultants in Colorado state court of conspiring to take its confidential information and form a "copycat" business, alleging they've deprived it of business opportunities and devalued its trade secrets.

  • April 13, 2026

    Disney, WB, Universal's AI Suit Is 'Artificial,' Tech Cos. Say

    Chinese artificial intelligence companies have urged a California federal court to throw out allegations from Disney, Warner Bros. Discovery and Universal that their service has been stealing the studios' intellectual property, calling it "ironic" that the case about artificial intelligence is "entirely artificial."

  • April 13, 2026

    Oracle Wins TRO Against Ex-Worker Threatening Secrets Sale

    A North Carolina federal judge Monday issued a temporary restraining order barring a recently laid-off Oracle sales employee from disclosing trade secrets that the software firm alleges he has threatened to sell to the "highest bidder" unless he receives an "unreasonable" fee.

  • April 13, 2026

    Citron's 'Shadowy Gang' Sued Over Short Selling Campaign

    Shareholders of PolarityTE have alleged in a new suit that "members of a shadowy gang of short sellers" conspired to short the biotechnology company's stock through targeted negative media attacks with Citron Research to enrich themselves at the expense of the shareholders, and that they ultimately caused the company's bankruptcy.

  • April 13, 2026

    Fed. Circ. Looks Askance At Sanctions In E-Banking IP Case

    A Federal Circuit panel on Monday appeared bothered by a lower court's nearly $85,000 sanctions order against a company and its counsel in its infringement lawsuit over an online banking patent, with one judge saying the record does not seem to support such action.

  • April 13, 2026

    NRA Fights To Keep Suit Against Foundation Alive

    The National Rifle Association has urged a Washington, D.C., federal judge to preserve its trademark and breach of contract suit against its charitable arm, saying the NRA has the right to bar the charitable organization from using its intellectual property.

  • April 13, 2026

    Mylan Can't Revive Copaxone Antitrust Claims Against Teva

    A New Jersey federal judge sided Monday with a special master's recommendations to nix some of the parallel claims from Mylan and retailers like Walgreens accusing Teva of using regulatory deception, false advertising, improper rebates and more to delay generic competition to its Copaxone multiple sclerosis treatment.

  • April 13, 2026

    Hikma Tells Justices Cox Ruling Boosts 'Skinny Label' Case

    Hikma Pharmaceuticals USA Inc. told the U.S. Supreme Court on Monday that the justices' recent decision clearing an internet company in a copyright case bolsters the drugmaker's challenge to a patent suit over its generic version of an Amarin Pharma Inc. heart drug.

Expert Analysis

  • Trade Secret Steps To Take As Exposure Risk Increases

    Author Photo

    Against the backdrop of rising trade secret litigation, greater employee mobility and constraints on noncompetes, recent cases highlight the importance of minimizing trade secret risks when employees leave or when new hires join, say attorneys at Sullivan & Cromwell.

  • Open Questions After Defense Contractor Executive Order

    Author Photo

    The scope and long-term effects of President Donald Trump’s executive order on the U.S. defense industrial base are uncertain, but the immediate impact is significant as it appears to direct the U.S. Department of Defense to take a more active role in contractor affairs, say attorneys at Morgan Lewis.

  • What Artists Can Learn From Latest AI Music Licensing Deals

    Author Photo

    Recent partnerships between music labels and artificial intelligence companies raise a number of key questions for artists, rightsholders and other industry players about IP, revenue-sharing, and rights and obligations, say attorneys at Manatt.

  • If Your AI Vendor Goes Bankrupt: Keeping Licensed IP Access

    Author Photo

    With contracting norms still evolving to account for the licensing of artificial intelligence tools, customers that need to retain access to key AI products in the event of vendor’s bankruptcy should consider four elements that could determine whether they may invoke traditional Section 365(n) intellectual property protections, say attorneys at Sidley.

  • USPTO's New Patentability Focus Helps Emerging Tech

    Author Photo

    The U.S. Patent and Trademark Office's recent efforts to shift patentability criteria back toward traditional standards of novelty, obviousness and adequate disclosure should make it easier for emerging tech, including artificial intelligence, to obtain patents, says Bill Braunlin at Barclay Damon.

  • Malpractice Claim Assignability Continues To Divide Courts

    Author Photo

    Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.

  • Tips For Financial Advisers Facing TRO From Former Firm

    Author Photo

    The Eighth Circuit's recent decision in Choreo v. Lors, overturning a lower court's sweeping injunction after financial advisers moved to a new firm, gives advisers new strategies to fight restraining orders from their old firms, such as focusing on whether the alleged irreparable harm is calculable, say attorneys at Kutak Rock.

  • Learning From A Typical Section 1782 Discovery Case

    Author Photo

    A California federal judge's recent approval of a Section 1782 application, compelling a U.S.-based company to produce materials relevant to a German patent dispute, usefully illustrates the specific steps foreign litigants must undertake before wielding this powerful tool for obtaining evidence unavailable via discovery mechanisms abroad, say attorneys at Fish & Richardson.

  • How To Trademark A Guy In 8 Ways: An IP Strategy Against AI

    Author Photo

    Attempting a novel method of protection against artificial intelligence misuse of his voice and likeness, Matthew McConaughey's recent efforts to register eight trademarks for a series of audio and video clips of himself underscore the importance of extending existing legal frameworks beyond traditional applications, says Summer Todd at Patterson Intellectual Property.

  • Utilizing The ITC To Combat 'Gray Market' IP Infringement

    Author Photo

    As technological developments intensify trademark owners' need to respond swiftly to "gray market" sales of international goods imported into the U.S. without the trademark owner's consent, litigating at the U.S. International Trade Commission offers an underutilized enforcement option, say attorneys at MoFo.

  • Series

    Teaching Logic Makes Me A Better Lawyer

    Author Photo

    Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.

  • From IPR To EPR: The Rapid Rise Of Ex Parte Reexamination

    Author Photo

    With the current administration's dramatic shifts in policy rendering inter partes reviews essentially unavailable for the majority of patents being asserted in litigation, IPR filing rates have plunged, and ex parte reexamination requests have surged to the average rate of IPR petitions in 2024, say attorneys at McKool Smith.

  • Series

    Law School's Missed Lessons: Practicing Resilience

    Author Photo

    Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.

  • Upshot Of 'Skinny Label' Case May Go Beyond Pharma

    Author Photo

    The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," carries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.

  • Assessing Factors Behind Biosimilar Uptake And Competition

    Author Photo

    As biosimilar uptake remains uneven and questions linger over whether the Biologics Price Competition and Innovation Act can deliver robust competition between biologics and biosimilars, a case study of Humira and its biosimilars illustrates how many factors, including payor reimbursement and formulary strategy, collectively shape competitive dynamics, say analysts at Analysis Group.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.